Even patients whose earlier surgery underperformed have a path forward through revision weight loss surgery
Led by Mayo Clinic physician and obesity expert Andres Acosta, MD, PhD, the research reveals that it is now possible to predict which patients are most likely to experience gastrointestinal (GI) side effects, particularly nausea the most common reason people discontinue these widely used weight-loss drugs, affecting up to 70% of users
+ iu tr ung th, cha lnh cc vt thng trn da
Elucidation of the molecular mechanisms underlying sorafenib-induced hepatotoxicity
These medications undergo rigorous clinical trials and quality control measures to help ensure safety, efficacy, and consistent dosing
However, results can vary, and it's important to consult with a healthcare provider before starting